<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>1989 (6) TMI 208 - CEGAT, NEW DELHI</title>
    <link>https://www.taxtmi.com/caselaws?id=80041</link>
    <description>The Tribunal ruled that the products Bituman Supplement Neftin-50 and Neftin-200 are classified under Tariff Item 14E of the Central Excise Tariff as patent or proprietary medicines for animals, not under Tariff Item 68. Consequently, the products were held liable to duty without the benefit of Notification No. 6/84. The decision emphasized that the classification should align with the statutory definition rather than trade understanding.</description>
    <language>en-us</language>
    <pubDate>Thu, 29 Jun 1989 00:00:00 +0530</pubDate>
    <lastBuildDate>Tue, 14 Jun 2011 12:47:02 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=117187" rel="self" type="application/rss+xml"/>
    <item>
      <title>1989 (6) TMI 208 - CEGAT, NEW DELHI</title>
      <link>https://www.taxtmi.com/caselaws?id=80041</link>
      <description>The Tribunal ruled that the products Bituman Supplement Neftin-50 and Neftin-200 are classified under Tariff Item 14E of the Central Excise Tariff as patent or proprietary medicines for animals, not under Tariff Item 68. Consequently, the products were held liable to duty without the benefit of Notification No. 6/84. The decision emphasized that the classification should align with the statutory definition rather than trade understanding.</description>
      <category>Case-Laws</category>
      <law>Central Excise</law>
      <pubDate>Thu, 29 Jun 1989 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=80041</guid>
    </item>
  </channel>
</rss>